Impact of clinical pharmacist intervention on diabetes related quality-of-life in an ambulatory care clinic

Pharmacy Practice

Volumn 5, Issue 4, 2007, Pages 169-173

  Jennings, Douglas L ^a   Ragucci, Kelly R ^b   Chumney, Elinor C G ^c   Wessell, Andrea M ^b  

^a WAYNE STATE UNIVERSITY   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Diabetes; Outcome Assessment (Health Care); Quality of life; United States

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; ATORVASTATIN; HEMOGLOBIN A1C; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AMBULATORY CARE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY IMAGE; CLINICAL ARTICLE; CLINICAL PHARMACY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; DRUG USE; DYSLIPIDEMIA; ELECTRONIC MEDICAL RECORD; FAMILY MEDICINE; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LIPID BLOOD LEVEL; LOGISTIC REGRESSION ANALYSIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATIENT CARE; PATIENT EDUCATION; PATIENT SATISFACTION; PHARMACIST; QUALITY OF LIFE; SCORING SYSTEM; SELF CONCEPT; SYSTOLIC BLOOD PRESSURE; TELEPHONE; UNITED STATES;

EID: 37349113380     PISSN: None     EISSN: 18863655     Source Type: Journal    
DOI: 10.4321/S1886-36552007000400005     Document Type: Article

References (17)

1. American Diabetes Association. Diabetes Statistics. URL http://www.diabetes.org/diabetes-statistics.jsp (accessed December 27, 2006).
2. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med 1993;329:977-86.
3. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulfonyureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
4. Keil PJ, McCord AD. Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice. Ann Pharmacother 2005;39:1828-32.
5. Morello CM, Zadvomy EB, Cording MA, Suemoto RT, Skog J, Harari A. Development and clinical outcomes of pharmacist-managed diabetes care clinics. Am J Health-Syst Pharm 2006;63:1325-31.
6. Scott DM, Boyd ST, Stephan M, Augustine SC, Reardon TP. Outcomes of pharmacist-managed diabetes care services in a community health center. Am J Health-Syst Pharm 2006;63:2116-22.
7. Ragucci KR, Fermo JD, Wessell AM, Chumney CG. Effectiveness of Pharmacist-Administered Diabetes Mellitis Education and Management Services. Pharmacotherapy 2005;25:1809-1816.
8. Cranor CW, Bunting BA, Christensen DB. The Ashville Project: Long-term Clinical and Economic Outcomes of a Community Pharmacy Diabetes Care Program. J Am Pharm Assoc 2003; 43:173.
9. Lial S, Glover JJ, Herrier RN, Felix A. Improving quality of care in diabetes through a comprehensive pharmacist-based disease management program. Diabetes Care 2004;27(12):2983-84.
10. The DCCT Research Group. Influence of intensive diabetes treatment on Quality-of-Life outcomes in the Diabetes Control and Complications Trial. Diabetes 1996;19:195-202.
11. Centers for Disease Control and Prevention. Self-rated fair or poor health among adults with diabetes-United States, 1996-2005. MMWR Morb Mortal Wkly Rep 2006;55(45):1224-7.
12. Baran RW, Crumlish K, Patterson H, Shaw J, Erwin WG, Wylie JD, Duong P. Improving outcomes of community-dwelling older patients with diabetes through pharmacist counseling. Am J Health-Syst Pharm 1999;56:1535-9.
13. Jaber LA, Halapy H, Femet M, Tummalapalli S, Diwakaran H. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother 1996;30:238-43.
14. Cranor CW, Christensen DB. The Ashville Project: Short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc 2003;43:149-59.
15. Standards of Medical Care in Diabetes. Diabetes Care 2007 30: S4-41.
16. The DCCT Research Group. Reliability and validity of a diabetes Quality-of-Life measure for the Diabetes Control and Complications Trial (DCCT). Diabetes Care 1988; 11:725-31.
17. Luscombe FA. Health-related quality of life measurement in type 2 diabetes. Value Health 2000;3(supp1):S15-28.